Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder COVID-Associated Exacerbation of Acute Psychosis in a Patient With Schizoaffective Disorder PDF $40.00
$40.00
× Placeholder Antipsychotic Medication and Oxidative Cell Stress: A Systematic Review PDF $40.00
$40.00
× Placeholder Suicide Attempts and Ideation in Patients With Bipolar I Disorder PDF $40.00
$40.00
× Placeholder A Critical Appraisal of Treatments for Bipolar Disorder PDF $40.00
$40.00
× Placeholder Preventive Cognitive Therapy With Antidepressant Discontinuation During Pregnancy: Results From a Randomized Controlled Trial PDF $0.00
$0.00
× Placeholder Using Dialectical Behavior Therapy to Treat Misophonia in Adolescence PDF $40.00
$40.00
× Placeholder The Course of Eating Disorders During COVID-19 PDF $40.00
$40.00
× Placeholder A Qualitative Study on Stigmatization Associated With COVID-19 PDF $40.00
$40.00
× Placeholder A Randomized Controlled Trial of Fluvoxamine in Prostatodynia, a Male Somatoform Pain Disorder PDF $40.00
$40.00
× Placeholder Psychometrics of the Violence Nonlinear Dynamics Scale PDF $40.00
$40.00
× Placeholder Comorbidity and Quality of Life in DSM-5 Social Anxiety Disorder Among a Nationally Representative Sample PDF $40.00
$40.00
× Placeholder Impact of CYP1A2 and CYP2D6 Polymorphisms on Drug Metabolism and on Insulin and Lipid Elevations and Insulin Resistance in Clozapine-Treated Patients PDF $40.00
$40.00
× Placeholder Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone PDF $40.00
$40.00
× Placeholder Psychocutaneous Medicine in Iraq: Current Status and Recommendations PDF $40.00
$40.00
× Placeholder Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia PDF $40.00
$40.00
× Placeholder The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases PDF $40.00
$40.00
× Placeholder Methylphenidate Treatment for Cocaine Abusers With Adult Attention-Deficit/Hyperactivity Disorder: A Pilot Study PDF $40.00
$40.00
× Placeholder Reduction of Opioid-Withdrawal Symptoms With Quetiapine PDF $40.00
$40.00
× Placeholder Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study PDF $40.00
$40.00
× Placeholder Correlates and Variation in Early Maladaptive Schema Domains Between Day 1 and Day 15 of Menses Among Lebanese Female University Students PDF $40.00
$40.00
× Placeholder Topiramate Treatment for SSRI-Induced Weight Gain in Anxiety Disorders PDF $40.00
$40.00
× Placeholder Treatment Nonadherence and Neurocognitive Impairment in Bipolar Disorder PDF $40.00
$40.00
× Placeholder Meta-Analysis of Suicidality in Placebo-Controlled Clinical Trials of Adults Taking Bupropion PDF $40.00
$40.00
× Placeholder The Co-occurrence of Gastrointestinal Symptoms and Psychosis: Diagnostic Considerations PDF $0.00
$0.00
× Placeholder Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder: Findings From a 12-Month Open-Label Study PDF $40.00
$40.00
× Placeholder Early Improvement Under Mirtazapine and Paroxetine Predicts Later Stable Response and Remission With High Sensitivity in Patients With Major Depression PDF $40.00
$40.00
× Placeholder Use of Face Masks Among Patients With Psychiatric Illnesses During the COVID-19 Pandemic: A Hospital-Based Cross-Sectional Study PDF $40.00
$40.00
× Placeholder Clozapine-Induced Fevers and 1-Year Clozapine Discontinuation Rate PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $1,040.00
Total $1,040.00